SARomics Biostructures
PrivateLast Round
Grant
Apr 2, 2020
Total Funding Raised
$1.53M
Company Overview
SARomics Biostructures operates in Healthcare & Life Sciences and is based in Lund. Its latest recorded funding round was a Grant round in April 2020.
SARomics Biostructures is a biotechnology company that provides structural biology and drug discovery outsourcing services, including X-ray crystallography and NMR spectroscopy, to support the entire drug development process.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SARomics Biostructures Comparables
Compare SARomics Biostructures with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Proteros Biostructures | 87% | |
| Domainex Ltd | 87% | |
| Oncodesign Services | 85% |
For institutional investors. Book with your work email.
SARomics Biostructures Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 2, 2020 | ||||
| Grant | Oct 5, 2017 | ||||
| Debt | Mar 6, 2014 | ||||
| Grant | Feb 5, 2014 | ||||
| Grant | Apr 1, 2013 | ||||
Seed | Sep 12, 2012 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
SARomics Biostructures Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lund University Innovation System AB | Seed |
| Eurostars SME programme | Grant |
| European Regional Development Fund | Seed |
| European Investment Fund | Debt |
| Swelife | Grant |
| European Union | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 19, 2026
Grew 19% QoQ, from 21 to 25 employees.
- Nov 7, 2025
Monthly visitors increased 49% MoM.
For institutional investors. Book with your work email.
SARomics Biostructures Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SARomics Biostructures's valuation, stock price, and market status.
Is SARomics Biostructures a public or private company?
SARomics Biostructures is a private company.
What is the current stock price of SARomics Biostructures?
SARomics Biostructures is a private company, so its shares have no public market price. Caplight tracks SARomics Biostructures's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SARomics Biostructures worth (valuation)?
Valuation information for SARomics Biostructures is not publicly available.
Can I buy SARomics Biostructures stock?
SARomics Biostructures shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SARomics Biostructures's last funding round?
SARomics Biostructures's most recent funding round was Grant on April 2, 2020.
Who are the main investors in SARomics Biostructures?
Key investors in SARomics Biostructures include Lund University Innovation System AB, Eurostars SME programme, European Regional Development Fund, European Investment Fund, Swelife.
Will SARomics Biostructures IPO soon?
No public IPO plans have been announced for SARomics Biostructures.
How can I track SARomics Biostructures secondary market activity?
Caplight tracks bids, offers, and trades in SARomics Biostructures's shares on secondary markets.